Additionally, CYP2C9 belongs to the cytochrome P450 2C (CYP2C) family and is critically CYP2C9, an enzyme involved in the metabolism of numerous carcinogens and pharmaceutical agents, exhibits significantly reduced expression in HCC (57). This evidence concerns the gene CYP2C9 and hepatocellular carcinoma.